Expanded recall for Franck's Compounds

Share this article:

The FDA is notifying all physicians and healthcare organizations of the recall of all sterile products sold by Franck's Compounding Pharmacy since November 2011 due to the possibility of lack of sterility.

In March 19, 2012, FDA received reports of fungal endophthalmitis in patients who were given Brilliant Blue G (BBG), supplied by Franck's Pharmacy, during eye surgeries. In April 20, 2012, FDA received reports of eye infections in patients who were given injections of Franck's drug products containing triamcinolone acetonide during eye surgery.

An active investigation by the CDC and FDA is ongoing at this time. FDA advises that any product received from Franck's since November 2011 not be used.

For more information visit http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm305592.htm.

Share this article:
You must be a registered member of Clinical Advisor to post a comment.

More in Web Exclusives

United States ranked last in access to health care

United States ranked last in access to health ...

Results of a 2013 survey indicate that three out of 10 Americans believe money is a barrier to receiving care.

Americans still consuming too much saturated, trans fat

Americans still consuming too much saturated, trans fat

Dietary guidelines from the American Heart Association indicate that Americans need fewer trans and saturated fats, and more omega-3 fatty acids in their diets.

Dietary supplements containing banned substances still on shelves

Dietary supplements containing banned substances still on shelves

Supplements used to enhance sports performance, weight loss, and sexual performance that contain FDA-banned substances are still being sold in stores.